References
- Barse R, Kokare C, Tagalpallewar A. Influence of hydroxypropylmethylcellulose and poloxamer composite on developed ophthalmic in situ gel: ex vivo and in vivo characterization. J Drug Deliv Sci Technol. 2016;33:66–74. doi:https://doi.org/10.1016/j.jddst.2016.03.011.
- Addepalli UK, Jonnadula GB, Garudadri CS, Khanna RC, Papas EB. Prevalence of primary glaucoma as diagnosed by study optometrists of L. V. Prasad eye institute–glaucoma epidemiology and molecular genetics study. Ophthalmic Epidemiol. 2019;26(3):150–54. doi:https://doi.org/10.1080/09286586.2018.1551961.
- Barse RK, Tagalpallewar AA, Kokare CR, Sharma JP, Sharma PK. Formulation and ex vivo–in vivo evaluation of PH-triggered brimonidine tartrate in situ gel for the glaucoma treatment using application of 32 factorial design. Drug Dev Ind Pharm. 2018;44(5):800–07. doi:https://doi.org/10.1080/03639045.2017.1414229.
- Morsi N, Ghorab D, Refat H, Teba H. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016;506(1–2):57–67. doi:https://doi.org/10.1016/j.ijpharm.2016.04.021.
- Silva AC, Amaral MH, González-Mira E, Santos D, Ferreira D. Solid Lipid Nanoparticles (SLN) - Based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies. Colloids Surfaces B Biointerfaces. 2012;93:241–48. doi:https://doi.org/10.1016/j.colsurfb.2012.01.014.
- Almeida KB, Ramos AS, Nunes JB, Silva BO, Ferraz ERA, Fernandes AS, Felzenszwalb I, Amaral ACF, Roullin VG, Falcão DQ, et al. Optimized by Box-Behnken for efficient encapsulation of therapeutic cymbopogon citratus essential oil. Colloids Surfaces B Biointerfaces. 2019;181:935–42. doi:https://doi.org/10.1016/j.colsurfb.2019.06.010.
- Gupta S, Samanta MK, Raichur AM. Dual-drug delivery system based on in situ gel-forming nanosuspension of forskolin to enhance antiglaucoma efficacy. AAPS Pharm Sci Tech. 2010;11(1):322–35. doi:https://doi.org/10.1208/s12249-010-9388-x.
- Ahmed VA, Goli D. Development and characterization of in situ gel of xanthan gum for ophthalmic formulation containing brimonidine tartrate. Asian J Pharm Clin Res. 2018;11(7):278–84. doi:https://doi.org/10.22159/ajpcr.2018.v11i7.25221.
- Patil A, Tagalpallewar A, Rasve G, Bendre A, Khapekar P. Formulation and evaluation of thermo-sensitive in situ gel of brimonidine tartrate. J Pharm Res. 2012;5:3597–601.
- Srividya B, Cardoza RM, Amin PD. Sustained ophthalmic delivery of ofloxacin from a PH triggered in situ gelling system. J Control Release. 2001;73(2–3):205–11. doi:https://doi.org/10.1016/S0168-3659(01)00279-6.
- Rathore KS. In-situ gelling ophthalmic drug delivery system: an overview. Int J Pharm and Pharm Sci. 2010;2:30–35.
- Shastri D, Pandya H, Parikh RK, PatelCN. Smart Gel in controlled drug delivery. Pharma Times. 2006;38:13–8.
- Quintanar-Guerrero D, Fessi H, Allémann E, Doelker E. Influence of stabilizing agents and preparative variables on the formation of Poly(D,L-Lactic Acid) nanoparticles by an emulsification-diffusion technique. Int J Pharm. 1996;143(2):133–41. doi:https://doi.org/10.1016/S0378-5173(96)04697-2.
- Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). J Control Release. 2002;80(1–3):129–44. doi:https://doi.org/10.1016/S0168-3659(02)00025-1.
- Alkholief M, Albasit H, Alhowyan A, Alshehri S, Raish M, Abul Kalam M, Alshamsan A. Employing a PLGA-TPGS based nanoparticle to improve the ocular delivery of acyclovir. Saudi Pharm J. 2019;27(2):293–302. doi:https://doi.org/10.1016/j.jsps.2018.11.011.
- Burke J, Schwartz M. Preclinical evaluation of brimonidine. Surv Ophthalmol. 1996;41:S9–S18. doi:https://doi.org/10.1016/S0039-6257(96)82027-3.
- Cantor LB. Brimonidine in the treatment of glaucoma and ocular hypertension. Ther Clin Risk Manag. 2006;2(4):337–46. doi:https://doi.org/10.2147/tcrm.2006.2.4.337.
- David R. Brimonidine (Alphagan®): a clinical profile four years after launch. Eur J of Ophth. 2001;11(2_suppl):72–77. doi:https://doi.org/10.1177/112067210101102S10.
- Fudemberg SJ, Batiste C, Katz LJ. Efficacy, safety, and current applications of brimonidine. Expert Opin Drug Saf. 2008 Nov 1;7(6):795–99. doi:https://doi.org/10.1517/17425250802457609.
- Singh KH, Shinde UA. Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane. Die Pharmazie-An Int J Pharmaceutical Sci. 2011 Aug 1;66(8):594–99.
- Ibrahim MM, Abd-Elgawad AE, Soliman OA, Jablonski MM. Novel topical ophthalmic formulations for management of glaucoma. Pharm Res. 2013 Nov;30(11):2818–31. doi:https://doi.org/10.1007/s11095-013-1109-1.
- Galanopoulos A, Goldberg I. Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension. Clinical Ophthalmol (Auckland, NZ). 2009;3:117.
- Aburahma MH, Mahmoud AA. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation. AAPS PharmSciTech. 2011;12(4):1335–47. doi:https://doi.org/10.1208/s12249-011-9701-3.
- Prabhu P, Kumar NR, Koland M, Harish NM, Vijayanarayan K, Dhondge G, Charyulu RN. Preparation and evaluation of nano-vesicles of brimonidine tartrate as an ocular drug delivery system. J Young Pharm. 2010;2(4):356–61. doi:https://doi.org/10.4103/0975-1483.71623.
- Bhagav P, Upadhyay H, Chandran S. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation optimization, in vitro and in vivo evaluation. AAPS PharmSciTech. 2011;12(4):1087–101. doi:https://doi.org/10.1208/s12249-011-9675-1.
- Hornig S, Heinze T, Becer CR, Schubert US. Synthetic polymeric nanoparticles by nanoprecipitation. J Mater Chem. 2009;23(19):3838–40. doi:https://doi.org/10.1039/b906556n.
- Ferreira SLC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandão GC, Da Silva EGP, Portugal LA, Dos Reis PS, Souza AS, et al. Box-Behnken design: an alternative for the optimization of analytical methods. Anal Chimica Acta. 2007;597(2):179–86. doi:https://doi.org/10.1016/j.aca.2007.07.011.
- Ghasemian E, Vatanara A, Rouholamini Najafabadi A, Rouini MR, Gilani K, Darabi M. Preparation characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design DARU. J Pharm Sci. 2013;21:1–10.
- Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int J Pharm. 1989;55(1):R1–R4. doi:https://doi.org/10.1016/0378-5173(89)90281-0.
- Sah AK, Suresh PK, Verma VK. PLGA nanoparticles for ocular delivery of loteprednol etabonate: a corneal penetration study. Artif Cells, Nanomedicine Biotechnol. 2017;45(6):1–9. doi:https://doi.org/10.1080/21691401.2016.1203794.
- Warsi MH, Anwar M, Garg V, Jain GK, Talegaonkar S, Ahmad FJ, Khar RK. Dorzolamide-Loaded PLGA/Vitamin E TPGS nanoparticles for glaucoma therapy: pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits. Colloids Surfaces B Biointerfaces. 2014;122(1):423–31. doi:https://doi.org/10.1016/j.colsurfb.2014.07.004.
- Ali H, Singh S, Preparation K. Characterization of solid lipid nanoparticles of furosemide using quality by design. Part Sci Technol. 2018;36(6):695–709. doi:https://doi.org/10.1080/02726351.2017.1295293.
- Attama AA, Reichl S, Müller-Goymann CC. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 2008;355(1–2):307–13. doi:https://doi.org/10.1016/j.ijpharm.2007.12.007.
- Staff OECD. OECD guidelines for the testing of chemicals. Fourteenth addendum. Paris, France: OECD; 2002.
- Velpandian T, Gupta P, Ravi AK, Sharma HP, Biswas NR. Evaluation of pharmacological activities and assessment of intraocular penetration of an ayurvedic polyherbal eye drop (Itone™) in experimental models. BMC Complement Altern Med. 2013 Dec;13(1):1–2. doi:https://doi.org/10.1186/1472-6882-13-1.
- Shahab MS, Rizwanullah M, Alshehri S, Imam SS. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: in vitro, ex vivo and toxicity assessments. Int J BiolMacromol. 2020 Nov;15(163):2392–404. doi:https://doi.org/10.1016/j.ijbiomac.2020.09.185.
- Mehra N, Aqil M, Sultana Y. A grafted copolymer-based nanomicelles for topical ocular delivery of everolimus: formulation, characterization, ex-vivo permeation, in-vitro ocular toxicity, and stability study. Eur J Pharm Sci. 2021 Apr;1(159):105735. doi:https://doi.org/10.1016/j.ejps.2021.105735.
- Budhian A, Siegel SJ, Winey KI. Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm. 2007;336(2):367–75. doi:https://doi.org/10.1016/j.ijpharm.2006.11.061.
- Ghosh S, Kar N, Bera T. Oleanolic acid loaded poly lactic co-glycolic acid-vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis. Int J Bio Macromol. 2016;93:961–70. doi:https://doi.org/10.1016/j.ijbiomac.2016.09.014.
- Jin X, Zhang Y, Zhang Z, Che D, Lv H. Juglone loaded poloxamer 188/Phospholipid mixed micelles evaluated in vitro and in vivo in breast cancer. Int J Pharm. 2016;515(1–2):359–66. doi:https://doi.org/10.1016/j.ijpharm.2016.10.027.
- Ashjari M, Khoee S, Mahdavian AR, Rahmatolahzadeh R. Self-assembled nanomicelles using PLGA-PEG amphiphilic block copolymer for insulin delivery: a physicochemical investigation and determination of CMC values. J Mater Sci Mater Med. 2012;23(4):943–53. doi:https://doi.org/10.1007/s10856-012-4562-1.
- Ravi PR, Aditya N, Kathuria H, Malekar S, Vats R. Lipid nanoparticles for oral delivery of raloxifene: optimization, stability, in vivo evaluation and uptake mechanism. Eur J Pharm Biopharm. 2014;87(1):114–24. doi:https://doi.org/10.1016/j.ejpb.2013.12.015.
- Perumal D. Microencapsulation of Ibuprofen and Eudragit® RS 100 by the emulsion solvent diffusion technique. Int J Pharm. 2001;218(1–2):1–11. doi:https://doi.org/10.1016/S0378-5173(00)00686-4.
- Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290(1–2):137–44. doi:https://doi.org/10.1016/j.ijpharm.2004.11.027.
- Hao J, Fang X, Zhou Y, Wang J, Guo F, Li F, Peng X. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine. 2011;6:683–92. doi:https://doi.org/10.2147/IJN.S17386.
- Cooper DL, Harirforoosh S. Effect of formulation variables on preparation of celecoxib loaded polylactide-Co-glycolide nanoparticles. PLoS One. 2014;18:1810–22.
- Kashif PM, Madni A, Ashfaq M, Rehman M, Mahmood MA, Khan MI, Tahir N. Development of Eudragit RS 100 microparticles loaded with ropinirole: optimization and in vitro evaluation studies. AAPS PharmSciTech. 2017;18(5):1810–22. doi:https://doi.org/10.1208/s12249-016-0653-5.
- Jamali Z, Khoobi M, Hejazi SM, Eivazi N, Abdolahpour S, Imanparast F, Moradi-Sardareh H, Paknejad M. Evaluation of targeted curcumin (CUR) loaded PLGA nanoparticles for in vitro photodynamic therapy on human glioblastoma cell line. Photo Diagnosis Photodyn Ther. 2018;18:1810–22.
- Rajavathsavai D, Khapre A, Munshi B. Study of mixing behavior of cstr using Cfd. Brazilian J Chem Eng. 2014;31:119–29. doi:https://doi.org/10.1590/S0104-66322014000100012.
- Gupta SK, Agarwal R, Galpalli ND, Srivastava S, Agrawal SS, Saxena R. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma. Find Exp Clin Pharmacol. 2007;29(10):665–72. doi:https://doi.org/10.1358/mf.2007.29.10.1147765.
- Kumar S, Dang S, Nigam K, Ali J, Baboota S. Selegiline nanoformulation in attenuation of oxidative stress and upregulation of dopamine in the brain for the treatment of Parkinson’s disease. Rejuvenation Res.2018;21:464–476.
- Sharma N, Madan P, Lin S. Effect of process and formulation variables on the preparation of parenteral paclitaxel-loaded biodegradable polymeric nanoparticles: a co-surfactant study. Asian J Pharma Sci. 2016;11:404–16.
- Vuddanda PR, Rajamanickam VM, Yaspal M, Singh S. Investigations on agglomeration and haemocompatibility of vitamin E TPGS surface modified berberine chloride nanoparticles. BioMed Res Int. 2014;1–11. doi:https://doi.org/10.1155/2014/951942.
- Gaonkar RH, Ganguly S, Dewanjee S, Sinha S, Gupta A, Ganguly S, Chattopadhyay D, ChatterjeeDebnath M. Garcinol loaded vitamin E TPGS emulsified PLGA nanoparticles: preparation, physicochemical characterization. In Vitro and in Vivo Studies Sci Rep. 2017;7(1):530–42. doi:https://doi.org/10.1038/s41598-017-00696-6.
- de Carvalho SM, Noronha CM, Floriani CL, Lino RC, Rocha G, Bellettini IC, Ogliari PJ, Barreto PLM. Optimization of α-tocopherol loaded solid lipid nanoparticles by central composite design. Ind Crops Prod. 2013;49:278–85. doi:https://doi.org/10.1016/j.indcrop.2013.04.054.
- Fakhari A, Corcoran M, Schwarz A. Thermogelling properties of purified poloxamer 407. Heliyon. 2017;3(8):1–26. doi:https://doi.org/10.1016/j.heliyon.2017.e00390.
- Almeida H, Amaral MH, Lobão P, Sousa Lobo JM. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview. Expert Opin Drug Deliv. 2013;10(9):1223–37. doi:https://doi.org/10.1517/17425247.2013.796360.
- El-Kamel AH. In vitro and in vivo evaluation of pluronic F127-based ocular delivery system for timolol maleate. Int J Pharm. 2002;241(1):47–55. doi:https://doi.org/10.1016/S0378-5173(02)00234-X.
- Wu C, Qi H, Chen W, Huang C, Su C, Li W, Hou S. Preparation and evaluation of a Carbopol®/HPMC-based in situ gelling ophthalmic system for puerarin. YakugakuZasshi. 2007;127:183–91.
- Nokhodchi A, Raja S, Patel P, Asare-Addo K. The role of oral controlled release matrix tablets in drug delivery systems. BioImpacts. 2012;2(4):175–87. doi:https://doi.org/10.5681/bi.2012.027.
- Abdelbary GA, Amin MM, Zakaria MY. Ocular ketoconazole-loaded proniosomal gels: formulation, ex vivo corneal permeation and in vivo studies. Drug Deliv. 2017;24(1):309–19. doi:https://doi.org/10.1080/10717544.2016.1247928.
- Fathalla ZM, Vangala A, Longman M, Khaled KA, Hussein AK, El-Garhy OH, Alany RG. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies. Eur J Pharm Biopharm. 2017;114:119–34. doi:https://doi.org/10.1016/j.ejpb.2017.01.008.
- Patel N, Thakkar V, Metalia V, Baldaniya L, Gandhi T, Gohel M. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Drug Dev Ind Pharm. 2016;42(9):1406–23. doi:https://doi.org/10.3109/03639045.2015.1137306.
- Wen Y, Ban J, Mo Z, Zhang Y, An P, Liu L, Xie Q, Du Y, Xie B, Zhan X, et al. A potential nanoparticle-loaded in situ gel for enhanced and sustained ophthalmic delivery of dexamethasone. Nanotechnology. 2018;29(42):1–24. doi:https://doi.org/10.1088/1361-6528/aad7da.
- Kakkar S, Kaur IP. Spanlastics—A novel nanovesicular carrier system for ocular delivery. Int J Pharma. 2011;413(2):202–10. doi:https://doi.org/10.1016/j.ijpharm.2011.04.027.
- Okur NÜ, Yozgatli V, Okur ME. In vitro-in vivo evaluation of tetrahydrozoline-loaded ocular in situ gels on rabbits for allergic conjunctivitis management. Drug Dev Res. 2020;81(6):716–27. doi:https://doi.org/10.1002/ddr.21677.
- Wang X, Zhang Y, Huang J, Tian C, Xia M, Liu L, Li Z, Cao J, Gui S, Chu X. A novel phytantriol-based lyotropic liquid crystalline gel for efficient ophthalmic delivery of pilocarpine nitrate.AAPS. PharmSciTech. 2019;20(1):32. doi:https://doi.org/10.1208/s12249-018-1248-0.
- Pang X, Li J, Pi J, Qi D, Guo P, Li N, Wu Y, Liu Z. Increasing efficacy and reducing systemic absorption of brimonidine tartrate ophthalmic gels in rabbits. Pharm Dev Technol. 2018;23(3):231–39. doi:https://doi.org/10.1080/10837450.2017.1328693.